Clanwilliam Group Ireland, has announced the completion of a €200m debt placement with Alcentra. The funding will provide Clanwilliam Group with an initial €200m of committed capital to refinance existing facilities and to finance near term acquisition opportunities. A further €100m of follow-on capital is earmarked for future growth in order to accelerate the Group’s global M&A ambitions.
Clanwilliam Group is a global provider of technology to healthcare professionals with offices in seven countries and customers in over twenty. In the last 5 years, the group has acquired 16 businesses providing technology and services in primary and secondary care settings globally, from Dublin, Ireland to Auckland, New Zealand.
Welcoming the announcement today Howard Beggs, CEO, Clanwilliam Group said:
“Todays investment by Alcentra in Clanwilliam Group is welcomed and will help to accelerate the ambitious M&A targets we have set for ourselves over the coming year. We’re hoping to complete two acquisitions before the end of year with plans to manage a pipeline of further transactions in 2019 that will see the Group expand its geographical reach into mainland Europe and North America.”
Alcentra are a global asset management firm with offices in London, New York, Boston, Singapore and Hong Kong. Alcentra’s investment in Clanwilliam Group is consistent with its investment strategy based on lending to attractive European companies that are looking to grow and diversify their capital sources. Natalia Tsitoura, Managing Director within Alcentra’s European Direct Lending Team commented: “We are very pleased to be partnering with Clanwilliam Group and its management team as it looks to execute its ambitious global growth strategy in the coming years.”
Clanwilliam group was advised by Foxford Advisors, London and its lead counsel, Dechert LLP, London on the transaction
For further information on Clanwilliam Group please visit our Explore section.